Q2  2024 |
≡ |
First Eagle Investment Management |
Add 13.47% |
6,000 |
0.00 |
≡ |
Christopher Davis - Davis Advisors |
Reduce 0.52% |
16,750 |
0.00 |
≡ |
Samantha McLemore - Patient Capital Management |
Sell 100.00% |
142,791 |
0.10 |
Q1  2024 |
≡ |
First Eagle Investment Management |
Add 24.94% |
8,891 |
0.00 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 59.97% |
213,886 |
0.15 |
≡ |
Christopher Davis - Davis Advisors |
Reduce 1.47% |
48,204 |
0.00 |
Q4  2023 |
≡ |
First Eagle Investment Management |
Add 1.42% |
500 |
0.00 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 10.08% |
40,000 |
0.03 |
≡ |
Christopher Davis - Davis Advisors |
Reduce 3.75% |
128,038 |
0.01 |
Q3  2023 |
≡ |
First Eagle Investment Management |
Add 11.99% |
3,764 |
0.00 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 19.47% |
95,923 |
0.05 |
≡ |
Christopher Davis - Davis Advisors |
Reduce 2.38% |
83,072 |
0.00 |
Q2  2023 |
≡ |
First Eagle Investment Management |
Add 90.60% |
14,919 |
0.00 |
≡ |
Christopher Davis - Davis Advisors |
Reduce 3.21% |
115,938 |
0.01 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 2.97% |
15,100 |
0.01 |
Q1  2023 |
≡ |
First Eagle Investment Management |
Buy |
16,466 |
0.00 |
≡ |
Christopher Davis - Davis Advisors |
Reduce 4.05% |
152,386 |
0.01 |
Q4  2022 |
≡ |
Christopher Davis - Davis Advisors |
Reduce 6.29% |
252,630 |
0.01 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 5.58% |
30,000 |
0.10 |
≡ |
ValueAct Capital |
Sell 100.00% |
1,296,027 |
0.14 |
Q3  2022 |
≡ |
ValueAct Capital |
Reduce 35.20% |
703,973 |
0.08 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 15.03% |
95,100 |
0.30 |
≡ |
Christopher Davis - Davis Advisors |
Reduce 2.16% |
88,787 |
0.00 |
Q2  2022 |
≡ |
Christopher Davis - Davis Advisors |
Add 0.05% |
2,073 |
0.00 |
≡ |
Samantha McLemore - Patient Capital Management |
Add 203.79% |
424,500 |
1.53 |
≡ |
ValueAct Capital |
Buy |
2,000,000 |
0.23 |
Q1  2022 |
≡ |
Christopher Davis - Davis Advisors |
Add 70.95% |
1,702,188 |
0.10 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 26.34% |
74,500 |
0.33 |
≡ |
Bill Miller - Miller Value Partners |
Sell 100.00% |
917,297 |
0.45 |
Q4  2021 |
≡ |
Bill Miller - Miller Value Partners |
Reduce 68.07% |
1,955,159 |
0.96 |
≡ |
Christopher Davis - Davis Advisors |
Reduce 1.22% |
29,521 |
0.00 |
Q3  2021 |
≡ |
Bill Miller - Miller Value Partners |
Reduce 10.67% |
343,048 |
0.19 |
≡ |
Christopher Davis - Davis Advisors |
Reduce 5.75% |
148,247 |
0.01 |
Q2  2021 |
≡ |
Bill Miller - Miller Value Partners |
Add 6.70% |
201,998 |
0.10 |
≡ |
Christopher Davis - Davis Advisors |
Buy |
2,576,921 |
0.20 |
≡ |
Daniel Loeb - Third Point |
Sell 100.00% |
1,500,000 |
0.23 |
Q1  2021 |
≡ |
Daniel Loeb - Third Point |
Buy |
1,500,000 |
0.23 |
≡ |
Bill Miller - Miller Value Partners |
Reduce 17.84% |
654,212 |
0.43 |
≡ |
Christopher Davis - Davis Advisors |
Sell 100.00% |
791,823 |
0.08 |
Q4  2020 |
≡ |
Christopher Davis - Davis Advisors |
Add 1.73% |
13,449 |
0.00 |
≡ |
Bill Miller - Miller Value Partners |
Add 63.96% |
1,430,753 |
0.97 |
Q3  2020 |
≡ |
Christopher Davis - Davis Advisors |
Buy |
778,374 |
0.09 |
≡ |
Bill Miller - Miller Value Partners |
Buy |
2,236,965 |
1.77 |